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Background: The relationship between gender and long-term prognosis in women and men with cardiovascular disease (CVD) has been 
recognized; however the research results are contradictory. Suboptimal treatment of women, as described in literature, could negatively influence 
their outcome. To exclude this effect, we investigated the risk of recurrent CVD and death in women and men with documented CVD, who received a 
similar secondary prevention therapy advice according to current guidelines.
Methods: 5349 patients (1347 women, 4002 men) with myocardial infarction, stroke, peripheral arterial disease or abdominal aortic aneurysm 
were included in the SMART study. They all received a standardized vascular screening with a personalized therapy advice. During follow-up 
all cardiovascular events were registered. The mean follow-up in women and men was 6 years. Our main outcome measures of interest were 
cardiovascular death and cardiovascular outcome, a composite of cardiovascular death, stroke and myocardial infarction. Survival free hazard 
ratios (HRs) were calculated in two different models using Cox Regression. The first model adjusted only for age while the second model (used in the 
results) adjusted for age and cardiovascular risk factors. Men served as the reference category. 
Results: Women and men had a mean age of 60 years. Women had a better long-term prognosis since they were less likely to die a cardiovascular 
death (HR 0.53 (95%CI: 0.40-0.69)) or develop the combined cardiovascular endpoint (HR 0.64 (95%CI: 0.53-0.78)). The different vascular beds 
involved could not explain this advantage, nor could the differences in risk factor profile. Possibly women are more adherent to the personalized 
therapy advice.
Conclusions: Women with documented CVD who received a similar secondary prevention therapy advice as men had a favorable long-term 
prognosis.
